Exploratory real-world experience with GLP-1 receptor agonists vs
As insurers seek to balance upfront costs, clinical benefits, and long-term cost savings, the story of GLP1 offers a compelling case study for actuaries and others who may be navigating the evolving healthcare landscape
The vials you are not actively using stay sealed, cold, and protected from every form of degradation except the slow, baseline chemical processes that cold temperatures already minimize
I just want to go to sleep all the time Hiya pinkypurple58, I am so sorry to hear u are in that cruel B12 cycle I have been there n can remember that buzz u get from the injection never lasted long
Of note, in people with advanced DKD, additional glucose-lowering beyond SGLT2 inhibition will be necessary, making GLP-1 receptor agonists valuable drugs in this population